Accenture (NYSE:ACN) and Salesforce (NYSE:CRM) are joining forces to enhance the Salesforce Life Sciences Cloud, focusing on data and AI-powered innovations. The companies are expanding their generative AI collaboration, creating new solutions via a generative AI acceleration hub. They aim to use Salesforce Data Cloud and Einstein AI to boost productivity and transform healthcare experiences.
Emma McGuigan from Accenture stressed the importance of data and AI in creating unique customer engagement experiences within life sciences organizations. She advocated for a digital foundation for omni-channel experiences. Accenture's research revealed that 58% of life sciences companies prioritize the rapid adoption of data and analytics capabilities.
Amit Khanna from Salesforce praised Accenture's industry knowledge in creating the next-generation Life Sciences Platform. He recognized the value Accenture's expertise in the pharma and medtech sectors brings to driving new innovations.
The key deliverables from this partnership include a Health Cloud assessment framework for analyzing legacy pharma patient services solutions, alongside a Data Cloud and Einstein AI accelerator that provides a comprehensive view of provider and patient data. Accenture has expressed its commitment to creating more tools to facilitate client testing of new features within Salesforce Life Sciences Cloud.
This partnership underscores the growing role of data and AI in reshaping customer engagement experiences within life sciences organizations. It also highlights the increasing trend towards digital-first strategies in modernizing patient engagement in the healthcare sector.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.